Aevi Genomic Medicine, Inc. (GNMX) has 18 open-market insider trades by 10 insiders since 2017. The most active filer is Sol J. Barer, Director.
| Name | Title | Tier | Trades | Value | Last Trade |
|---|---|---|---|---|---|
| Sol J. Barer | Dir | — | 5 | $7.3M | 2019-12-05 |
| Children's Hospital of Philadelphia Foundation via Sol J. Barer | 10% Owner | — | 1 | $2.4M | 2020-02-03 |
| Philip R. Harper | 10% Owner | — | 3 | $2.0M | 2017-08-23 |
| Michael F. Cola | CEOPres | — | 2 | $833K | 2020-02-03 |
| Garry Arthur Neil | CSO | — | 2 | $627K | 2020-02-03 |
| Barbara Gayle Duncan | Dir | — | 1 | $150K | 2020-02-03 |
| Wilbur H. Gantz | Dir | — | 1 | $100K | 2017-10-17 |
| Joseph J. Grano Jr. | Dir | — | 1 | $79K | 2020-02-03 |
| Eugene A. Bauer | Dir | — | 1 | $25K | 2020-02-03 |
| Alastair J. Clemow | Dir | — | 1 | $25K | 2020-02-03 |
| Insider | Title | Type | Value | Date |
|---|---|---|---|---|
| Sol J. Barer | Director | Sell | $1.1M | 2019-12-05 |
| Michael F. Cola | CEO & President | Buy | $533K | 2019-12-05 |
| Joseph J. Grano Jr. | Director | Buy | $79K | 2018-11-07 |
| Children's Hospital of Philadelphia Foundation | 10% | Buy | $2.4M | 2018-08-15 |
| Sol J. Barer | Director | Buy | $4.9M | 2018-08-15 |
| Michael F. Cola | CEO & President | Buy | $300K |
Companies that share insiders with GNMX, and sector peers with recent insider buying. Related by who files, not by how the stocks move.
| 2017-10-17 |
| Sol J. Barer | Director | Buy | $1.1M | 2017-10-17 |
| Barbara Gayle Duncan | Director | Buy | $150K | 2017-10-17 |
| Wilbur H. Gantz | Director | Buy | $100K | 2017-10-17 |
| Garry Arthur Neil | CSO | Buy | $95K | 2017-10-17 |
| Eugene A. Bauer | Director | Buy | $25K | 2017-10-17 |
| Joseph J. Grano Jr. | Director | Buy | $50K | 2017-10-17 |
| Philip R. Harper | 10% | Buy | $12K | 2017-08-22 |
| Philip R. Harper | 10% | Buy | $24K | 2017-08-10 |
| Sol J. Barer | Director | Buy | $157K | 2017-04-28 |